Hanby AM - Search Results

1

CIP2A expression predicts recurrences of tamoxifen-treated breast cancer.

Baldacchino S, Wastall LM, Saliba C, Hughes TA, Scerri C, Berwick A, Speirs V, Hanby AM, Grech G. Baldacchino S, et al. Among authors: hanby am. Tumour Biol. 2017 Oct;39(10):1010428317722064. doi: 10.1177/1010428317722064. Tumour Biol. 2017. PMID: 29034804 Free article.

2

Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts.

Verghese ET, Shenoy H, Cookson VJ, Green CA, Howarth J, Partanen RH, Pollock S, Waterworth A, Speirs V, Hughes TA, Hanby AM. Verghese ET, et al. Among authors: hanby am. Histopathology. 2011 Oct;59(4):609-18. doi: 10.1111/j.1365-2559.2011.03917.x. Histopathology. 2011. PMID: 22014042

3

Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.

Simpkins SA, Hanby AM, Holliday DL, Speirs V. Simpkins SA, et al. Among authors: hanby am. J Pathol. 2012 Aug;227(4):490-8. doi: 10.1002/path.4034. Epub 2012 May 23. J Pathol. 2012. PMID: 22488553

4

Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer.

Kim B, Fatayer H, Hanby AM, Horgan K, Perry SL, Valleley EM, Verghese ET, Williams BJ, Thorne JL, Hughes TA. Kim B, et al. Among authors: hanby am. PLoS One. 2013 May 2;8(5):e62766. doi: 10.1371/journal.pone.0062766. Print 2013. PLoS One. 2013. PMID: 23658771 Free PMC article.

5

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

Verghese ET, Drury R, Green CA, Holliday DL, Lu X, Nash C, Speirs V, Thorne JL, Thygesen HH, Zougman A, Hull MA, Hanby AM, Hughes TA. Verghese ET, et al. Among authors: hanby am. J Pathol. 2013 Nov;231(3):388-99. doi: 10.1002/path.4248. J Pathol. 2013. PMID: 23939832 Free PMC article.

6

External validation of the ImmunoRatio image analysis application for ERα determination in breast cancer.

Sundara Rajan S, Horgan K, Speirs V, Hanby AM. Sundara Rajan S, et al. Among authors: hanby am. J Clin Pathol. 2014 Jan;67(1):72-5. doi: 10.1136/jclinpath-2013-201680. Epub 2013 Aug 28. J Clin Pathol. 2014. PMID: 23986557

7

Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.

Al-Nakhle H, Smith L, Bell SM, Burns PA, Cummings M, Hanby AM, Lane S, Parker MD, Hughes TA, Speirs V. Al-Nakhle H, et al. Among authors: hanby am. Int J Oncol. 2013 Dec;43(6):2039-45. doi: 10.3892/ijo.2013.2112. Epub 2013 Sep 25. Int J Oncol. 2013. PMID: 24068253

8

The potential utility of geminin as a predictive biomarker in breast cancer.

Sundara Rajan S, Hanby AM, Horgan K, Thygesen HH, Speirs V. Sundara Rajan S, et al. Among authors: hanby am. Breast Cancer Res Treat. 2014 Jan;143(1):91-8. doi: 10.1007/s10549-013-2786-5. Epub 2013 Dec 1. Breast Cancer Res Treat. 2014. PMID: 24292956

9

Steroid hormone receptor expression in breast cancer stroma.

Booth ME, Hanby AM, Speirs V. Booth ME, et al. Among authors: hanby am. Breast Cancer Res Treat. 2014 Feb;143(3):605-7. doi: 10.1007/s10549-013-2815-4. Epub 2014 Jan 24. Breast Cancer Res Treat. 2014. PMID: 24458844 No abstract available.

10

PSMD9 expression predicts radiotherapy response in breast cancer.

Langlands FE, Dodwell D, Hanby AM, Horgan K, Millican-Slater RA, Speirs V, Verghese ET, Smith L, Hughes TA. Langlands FE, et al. Among authors: hanby am. Mol Cancer. 2014 Mar 28;13:73. doi: 10.1186/1476-4598-13-73. Mol Cancer. 2014. PMID: 24673853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page